Depolarization of autofluorescence from malignant and normal human breast tissues

2001 ◽  
Vol 40 (7) ◽  
pp. 1147 ◽  
Author(s):  
Samarendra K. Mohanty ◽  
Nirmalya Ghosh ◽  
Shovan K. Majumder ◽  
Pradeep K. Gupta
2022 ◽  
Vol 3 (1) ◽  
pp. 101047
Author(s):  
Poornima Bhat-Nakshatri ◽  
Natascia Marino ◽  
Hongyu Gao ◽  
Yunlong Liu ◽  
Anna Maria Storniolo ◽  
...  

Author(s):  
Kjell A. Kvistad ◽  
Inger J. Bakken ◽  
Ingrid S. Gribbestad ◽  
Benny Ehrnholm ◽  
Steinar Lundgren ◽  
...  

Author(s):  
Aleksandra M. Ochnik ◽  
Nicole L. Moore ◽  
Tanja Jankovic-Karasoulos ◽  
Tina Bianco-Miotto ◽  
Natalie K. Ryan ◽  
...  

Author(s):  
A. P. M. Forrest

In some ways, this splendid conference marks the end of a road and I doubt if another will be held under the same title. Not that there is not much fundamental work still to be done on the mechanism of oestrogen action and its effects on normal and diseased breast tissues, but its general role in relation to breast cancer would appear now to be clear. Oestrogens are necessary for the development of the normal human breast, for the initiation and promotion of breast cancer, and may even act as a mitogen in established disease. But their role can be regarded as largely permissive. It is not clear that excess oestrogens are in any way causative of breast cancer in humans.


2006 ◽  
Vol 13 (2) ◽  
pp. 617-628 ◽  
Author(s):  
C L Wilson ◽  
A H Sims ◽  
A Howell ◽  
C J Miller ◽  
R B Clarke

Oestrogen (E) is essential for normal and cancer development in the breast, while anti-oestrogens have been shown to reduce the risk of the disease. However, little is known about the effect of E on gene expression in the normal human breast, particularly when the epithelium and stroma are intact. Previous expression profiles of the response to E have been performed on tumour cell lines, in the absence of stroma. We investigated gene expression in normal human breast tissue transplanted into 9–10-week-old female athymic nude (Balb/c nu/nu) mice. After 2 weeks, when epithelial proliferation is minimal, one-third of the mice were treated with 17β-oestradiol (E2) to give human luteal-phase levels in the mouse, which we have previously shown to induce maximal epithelial cell proliferation. RNA was isolated from treated and untreated mice, labelled and hybridized to Affymetrix HG-U133A (human) GeneChips. Gene expression levels were generated using BioConductor implementations of the RMA and MAS5 algorithms. E2 treatment was found to represent the largest source of variation in gene expression and cross-species hybridization of mouse RNA from xenograft samples was demonstrated to be negligible. Known E2-responsive genes (such as TFF1 and AREG), and genes thought to be involved in breast cancer metastasis (including mammoglobin, KRT19 and AGR2), were upregulated in response to E treatment. Genes known to be co-expressed with E receptor α in breast cancer cell lines and tumours were both upregulated (XBP-1 and GREB1) and downregulated (RARRES1 and GATA3). In addition, genes that are normally expressed in the myoepithelium and extracellular matrix that maintain the tissue microenvironment were also differentially expressed. This suggests that the response to oestrogen in normal breast is highly dependent upon epithelial–stromal/myoepithelial interactions which maintain the tissue microenvironment during epithelial cell proliferation.


Sign in / Sign up

Export Citation Format

Share Document